3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Uterine Cervical Neoplasms
2
Oropharyngeal Neoplasms
2
Hodgkin Disease
2
Cholangiocarcinoma
2
Carcinoma, Hepatocellular
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Ovarian Neoplasms
1
Neoplasms
1
Mesothelioma
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lung Neoplasms
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Plasma Cell
1
Glioma
1
Disease
1
Carcinoma, Squamous Cell
1
Interventions
Cyclophosphamide
3
sodium-iodide symporter
1
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
cemiplimab
1
X-Rays
1
Whole-Body Irradiation
1
Vorinostat
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Photons
1
Peripheral Blood Stem Cell Transplantation
1
Particle Accelerators
1
Nivolumab
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunoglobulin G
1
Etoposide
1
Disulfides
1
Cyclosporine
1
CTLA-4 Antigen
1
Busulfan
1
Biopsy
1
A-dmDT390-bisFv(UCHT1) protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
Fluorodeoxyglucose F18
×
30 days
×
Clear all
No trials found.